Regulation of cytotoxic T-cell differentiation and exhaustion by mTOR signaling

Researchers describe molecular signalling regulated by mTOR among memory and exhausted cytotoxic CD8+ T lymphocytes.

Young biotech venture firm raises $500 million for its second fund

What happens when two computer scientists and a former stem cell researcher become friends while working their way up the venture capital corporate ladder and

December 9, 2024

FDA approves Takeda’s Adzynma for rare blood clotting disorder

Takeda’s Adzynma is indicated for use as a prophylactic and on-demand therapy in adult and paediatric cTTP patients. Credit: Takeda Pharmaceutical Company Limited. The US

November 10, 2023

Opinion | ‘Only Side Effects Are Good Ones’: What We Heard This Week

“The only side effects are good ones.” — Dean Ornish, MD, of the University of California San Francisco, discussing an intensive lifestyle intervention that may

June 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.